Amanote Research
Register
Sign In
P3.03-10 Transcriptomic Differences Between Early and Late Stage Lung Adenocarcinoma
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.1687
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
D. Yue
B. Zhang
R. Lin
N. Li
T. Wang
L. Gao
C. Chen
C. Wang
Publisher
Elsevier BV
Related search
Stratifin Accelerates Progression of Lung Adenocarcinoma at an Early Stage
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Left Lung Torsion: Complication of Lobar Resection for an Early Stage Lung Adenocarcinoma
Case Reports in Critical Care
SCD1 Is Associated With Tumor Promotion, Late Stage and Poor Survival in Lung Adenocarcinoma
Oncotarget
Oncology
Editorial: Arthritis Pain: Moving Between Early- And Late-Stage Disease
Arthritis and Rheumatology
Rheumatology
Allergy
Immunology
P3.03-05 Comparative Transcriptomic Analysis of Lung-iPSC, NSCLC, and SCLC: Potential Implications for iPSC Modeling of Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Identification of Differentially‑expressed Genes Between Early‑stage Adenocarcinoma and Squamous Cell Carcinoma Lung Cancer Using Meta‑analysis Methods
Oncology Letters
Cancer Research
Oncology
Classification and Survival Prediction for Early‑stage Lung Adenocarcinoma and Squamous Cell Carcinoma Patients
Oncology Letters
Cancer Research
Oncology
P3.03-18 Collagen Type XI Promotes Lung Adenocarcinoma Dissemination via Integrin Α2 and DDR1
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Trans-Omics Biomarker Model Improves Prognostic Prediction Accuracy for Early-Stage Lung Adenocarcinoma
Aging
Aging
Cell Biology
